"As a member of our Board of Advisors, Dr. Yu will be extremely helpful in China BioPharma's focus in developing our current portfolio of vaccines and research products covering such areas as highly pathogenic viruses and cancer drugs.
I think the only reason this stock is down because Wall Street only reads the byline (AVI delays HEP C trial results). I have a very good friend at Morgan Stanley (MD/MBA) and he follows 30 to 50 biotech stocks at any one time. He doesn't parse the press release as some of our more astute scientists do and just goes by the byline. He emailed today about the bad news. I think that gives us a great opportunity and also makes me more and more skeptical of the "efficient market theory." I also don't think there is much market manipulation going on here. Wall Street is selling on the news, retail shorts are joining in, and as someone posted before, option market makers are now unwinding their stock purchases now that news is not going to happen this week. Option market makers are 100% neutral on the direction of the stock so the stock they purchased to hedge the massive April calls they wrote are being sold. Once people start buying May and June calls, I think the stock will recover and hopefully Cook or some other corner of AVI's vast universe of projects will give us some good news.
Yes, WS is ignorant to science, and that is the fact; but there are many investors with small money and average sofistication, and they follow WS no more than they listen to Cramar. Their main source of info is message board, and lucky them having on this board at least dozen of truly knowledgeable and honest members that help navigate through such unknown, dangerouse and misterious time zone into better, healthier life... for all of us,... 'longs' and 'shorts'.